Electrolysis of Direct Seawater: Challenges, Strategies, and Future Prospects †
Chinese Journal of Chemistry · 2023-12 · 41 (23) · 3484-3492
DOI: 10.1002/cjoc.202300324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Chemistry, online erschienen am 14.09.2023. Verfasst von Lin Hu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Comprehensive Summary The use of renewable sources such as solar, ocean, geothermal, and wind energy to drive water electrolysis reactions to obtain green and clean hydrogen fuels is one of the important paths to achieve sustainable energy development. At present, most water electrolysis technologies need to conduct corresponding pre‐processing, such as diluting water sources and purifying dehydration, which will greatly increase operating costs. The development of direct seawater electrolytic process can effectively solve the above problems. Here, we review the latest progress of the electrode materials and catalysts of the direct electrolysis process of seawater, and discuss how to design high activity and high‐selective electrode materials for water electrolysis with familiar impurities (such as chloride, metal ions and biological organisms) existing in the future.
Zitieren
APA
Hu, L., Tan, X., Yang, X., & Zhang, K. (2023). Electrolysis of Direct Seawater: Challenges, Strategies, and Future Prospects †. Chinese Journal of Chemistry, 41(23), 3484-3492. https://doi.org/10.1002/cjoc.202300324
Vancouver
Hu L, Tan X, Yang X, Zhang K. Electrolysis of Direct Seawater: Challenges, Strategies, and Future Prospects †. Chinese Journal of Chemistry. 2023;41(23):3484-3492. doi:10.1002/cjoc.202300324
BibTeX
@article{Hu2023,
author = {Hu, Lin and Tan, Xiao and Yang, Xuhao and Zhang, Kan},
title = {Electrolysis of Direct Seawater: Challenges, Strategies, and Future Prospects †},
journal = {Chinese Journal of Chemistry},
year = {2023},
volume = {41},
number = {23},
pages = {3484--3492},
doi = {10.1002/cjoc.202300324}
}
EUVIMED